Willard Dere Ph.D.
He is the Professor of Medicine, Executive director of Personalized Health, Co-Director, Center for Clinical and Translational Science at the University of Utah, Board Member of BioMalin Pharmaceutical and Director of Ocera Therapeutics. Former Vice President of Eli Lilly, Director of Radius Health. He was responsible for the clinical development of Raloxifene and other antitumor drugs, inflammation drugs and medications for kidney diseases when he worked as vice president of global development and international and Chief Medical Officer in Amgen. MD in University of California, Davis.




Arindam Bose Ph.D.
Over 30 years of experience in the pharmaceutical industry. He is committed to the production of biological agents and the production of biological pharmaceutical industry for the professional social organization services, advisors as a biological product development and manufacturing consultants. Former Pfizer project leader, executive director, vice president of external affairs and biosimil strategy, responsible for clinical and commercial manufacturing strategies. AIMBE, AIChE, ACS member. Purdue University Doctor of Chemical Engineering.



Dan Wu Ph.D.
Tenured Professor of Pharmacology in the Yale University. Member of The Recruitment Program of Global Experts. PhD in Clarkson University. He carried out researches of Signal Transduction in CIT and Yale successively, publishing over 100 articles & Reviews in top scientific journals like Nature and Cell. He has undertaken 5 NIH-sponsored projects currently and in totaltotally 24 research projects supported by various associations or the government like NIH.